Education
About Us
Working with TipRanks
Follow Us
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 22.60M | $ 34.16M | $ 19.23M | $ 1.32M | $ 430.00K |
| Gross Profit | $ 22.60M | $ -75.53M | $ 19.21M | $ -6.20M | $ -57.28M |
| Operating Income | $ -102.68M | $ -107.91M | $ -117.14M | $ -100.73M | $ -68.53M |
| EBITDA | $ -97.17M | $ -104.45M | $ -113.82M | $ -96.19M | $ -66.49M |
| Net Income | $ -86.62M | $ -98.43M | $ -108.87M | $ -103.23M | $ -69.78M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 243.75M | $ 234.06M | $ 345.80M | $ 154.29M | $ 185.77M |
| Total Assets | $ 283.98M | $ 285.92M | $ 404.88M | $ 519.77M | $ 255.59M |
| Total Debt | $ 37.13M | $ 45.07M | $ 51.51M | $ 58.33M | $ 82.00M |
| Net Debt | $ -18.32M | $ -35.26M | $ -294.29M | $ -42.80M | $ -10.80M |
| Total Liabilities | $ 329.51M | $ 363.11M | $ 404.77M | $ 422.90M | $ 109.41M |
| Stockholders' Equity | $ -45.53M | $ -77.19M | $ 112.00K | $ 96.87M | $ 146.19M |
| Cash Flow | |||||
| Free Cash Flow | $ -101.31M | $ -119.33M | $ 192.40M | $ -53.56M | $ -47.47M |
| Operating Cash Flow | $ -100.41M | $ -118.11M | $ 193.61M | $ -50.25M | $ -31.29M |
| Investing Cash Flow | $ -29.90M | $ 144.45M | $ -244.32M | $ 36.17M | $ -108.91M |
| Financing Cash Flow | $ 105.43M | $ 1.78M | $ 1.76M | $ 22.42M | $ 217.47M |